215 related articles for article (PubMed ID: 36617980)
1. Performance of a cell-free DNA prenatal screening test, choice of prenatal procedure, and chromosome conditions identified during pregnancy after low-risk cell-free DNA screening.
Scarff KL; Flowers N; Love CJ; Archibald AD; Hunt CE; Giouzeppos O; Elliott J; Delatycki MB; Pertile MD
Prenat Diagn; 2023 Feb; 43(2):213-225. PubMed ID: 36617980
[TBL] [Abstract][Full Text] [Related]
2. Genomics-based non-invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women.
Badeau M; Lindsay C; Blais J; Nshimyumukiza L; Takwoingi Y; Langlois S; Légaré F; Giguère Y; Turgeon AF; Witteman W; Rousseau F
Cochrane Database Syst Rev; 2017 Nov; 11(11):CD011767. PubMed ID: 29125628
[TBL] [Abstract][Full Text] [Related]
3. State-wide utilization and performance of traditional and cell-free DNA-based prenatal testing pathways: the Victorian Perinatal Record Linkage (PeRL) study.
Lindquist A; Hui L; Poulton A; Kluckow E; Hutchinson B; Pertile MD; Bonacquisto L; Gugasyan L; Kulkarni A; Harraway J; Howden A; McCoy R; Da Silva Costa F; Menezes M; Palma-Dias R; Nisbet D; Martin N; Bethune M; Poulakis Z; Halliday J
Ultrasound Obstet Gynecol; 2020 Aug; 56(2):215-224. PubMed ID: 31625225
[TBL] [Abstract][Full Text] [Related]
4. Contingent first-trimester screening for aneuploidies with cell-free DNA in a Danish clinical setting.
Miltoft CB; Rode L; Ekelund CK; Sundberg K; Kjaergaard S; Zingenberg H; Tabor A
Ultrasound Obstet Gynecol; 2018 Apr; 51(4):470-479. PubMed ID: 28640470
[TBL] [Abstract][Full Text] [Related]
5. Non-invasive cell-free fetal DNA testing for aneuploidy: multicenter study of 31 515 singleton pregnancies in southeastern China.
Xu L; Huang H; Lin N; Wang Y; He D; Zhang M; Chen M; Chen L; Lin Y
Ultrasound Obstet Gynecol; 2020 Feb; 55(2):242-247. PubMed ID: 31364782
[TBL] [Abstract][Full Text] [Related]
6. [Retrospective analysis of cell-free fetal DNA prenatal testing of maternal peripheral blood].
Wei Y; Wang R; Xi M; Wei L; Zhu W; Liu Y
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2023 Aug; 40(8):933-938. PubMed ID: 37532491
[TBL] [Abstract][Full Text] [Related]
7. [Analysis of follow-up information and pregnancy outcomes of cell free DNA prenatal screening].
Liang D; Lin Y; Li H; Hu P; Xu ZF
Zhonghua Fu Chan Ke Za Zhi; 2020 Feb; 55(2):106-111. PubMed ID: 32146739
[No Abstract] [Full Text] [Related]
8. Clinical performance of non-invasive prenatal served as a first-tier screening test for trisomy 21, 18, 13 and sex chromosome aneuploidy in a pilot city in China.
Liu Y; Liu H; He Y; Xu W; Ma Q; He Y; Lei W; Chen G; He Z; Huang J; Liu J; Liu Y; Huang Q; Yu F
Hum Genomics; 2020 Jun; 14(1):21. PubMed ID: 32503639
[TBL] [Abstract][Full Text] [Related]
9. Performance of prenatal cfDNA screening for sex chromosomes.
Martin K; Dar P; MacPherson C; Egbert M; Demko Z; Parmar S; Hashimoto K; Haeri S; Malone F; Wapner RJ; Roman AS; Khalil A; Faro R; Madankumar R; Strong N; Silver RM; Vohra N; Hyett J; Rabinowitz M; Kao C; Hakonarson H; Jacobsson B; Norton ME
Genet Med; 2023 Aug; 25(8):100879. PubMed ID: 37154148
[TBL] [Abstract][Full Text] [Related]
10. Cytogenetic outcomes following a failed cell-free DNA screen: a population-based retrospective cohort study of 35,146 singleton pregnancies.
Bellai-Dussault K; Meng L; Howley H; Reszel J; Huang T; Lanes A; Walker MC; Okun N; Dougan SD; Armour CM
Am J Obstet Gynecol; 2023 Aug; 229(2):168.e1-168.e8. PubMed ID: 36627072
[TBL] [Abstract][Full Text] [Related]
11. Clinical implementation of routine screening for fetal trisomies in the UK NHS: cell-free DNA test contingent on results from first-trimester combined test.
Gil MM; Revello R; Poon LC; Akolekar R; Nicolaides KH
Ultrasound Obstet Gynecol; 2016 Jan; 47(1):45-52. PubMed ID: 26498918
[TBL] [Abstract][Full Text] [Related]
12. Performance of cell-free DNA sequencing-based non-invasive prenatal testing: experience on 36,456 singleton and multiple pregnancies.
La Verde M; De Falco L; Torella A; Savarese G; Savarese P; Ruggiero R; Conte A; Fico V; Torella M; Fico A
BMC Med Genomics; 2021 Mar; 14(1):93. PubMed ID: 33785045
[TBL] [Abstract][Full Text] [Related]
13. Clinical application of expanded noninvasive prenatal testing for fetal chromosome abnormalities in a cohort of 39,580 pregnancies.
Chen Y; Lu L; Zhang Y; Wang F; Ni Y; Wang Q; Ying C
Am J Med Genet A; 2022 May; 188(5):1426-1434. PubMed ID: 35107205
[TBL] [Abstract][Full Text] [Related]
14. Positive predictive value estimates for cell-free noninvasive prenatal screening from data of a large referral genetic diagnostic laboratory.
Petersen AK; Cheung SW; Smith JL; Bi W; Ward PA; Peacock S; Braxton A; Van Den Veyver IB; Breman AM
Am J Obstet Gynecol; 2017 Dec; 217(6):691.e1-691.e6. PubMed ID: 29032050
[TBL] [Abstract][Full Text] [Related]
15. Clinical utility of noninvasive prenatal screening for expanded chromosome disease syndromes.
Liang D; Cram DS; Tan H; Linpeng S; Liu Y; Sun H; Zhang Y; Tian F; Zhu H; Xu M; Wang H; Yu F; Wu L
Genet Med; 2019 Sep; 21(9):1998-2006. PubMed ID: 30828085
[TBL] [Abstract][Full Text] [Related]
16. The accuracy and feasibility of noninvasive prenatal testing in a consecutive series of 20,626 pregnancies with different clinical characteristics.
Zheng Y; Li J; Zhang J; Yang H
J Clin Lab Anal; 2022 Oct; 36(10):e24660. PubMed ID: 36099005
[TBL] [Abstract][Full Text] [Related]
17. Use of a DNA method, QF-PCR, in the prenatal diagnosis of fetal aneuploidies.
Langlois S; Duncan A; ;
J Obstet Gynaecol Can; 2011 Sep; 33(9):955-960. PubMed ID: 21923994
[TBL] [Abstract][Full Text] [Related]
18. DNA sequencing versus standard prenatal aneuploidy screening.
Bianchi DW; Parker RL; Wentworth J; Madankumar R; Saffer C; Das AF; Craig JA; Chudova DI; Devers PL; Jones KW; Oliver K; Rava RP; Sehnert AJ;
N Engl J Med; 2014 Feb; 370(9):799-808. PubMed ID: 24571752
[TBL] [Abstract][Full Text] [Related]
19. Late first-trimester ultrasound findings can alter management after high-risk NIPT result.
Scott F; Smet ME; Elhindi J; Mogra R; Sunderland L; Ferreira A; Menezes M; Meagher S; McLennan A
Ultrasound Obstet Gynecol; 2023 Oct; 62(4):497-503. PubMed ID: 37247395
[TBL] [Abstract][Full Text] [Related]
20. Prenatal cell-free DNA screening for fetal aneuploidy in pregnant women at average or high risk: Results from a large US clinical laboratory.
Guy C; Haji-Sheikhi F; Rowland CM; Anderson B; Owen R; Lacbawan FL; Alagia DP
Mol Genet Genomic Med; 2019 Mar; 7(3):e545. PubMed ID: 30706702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
